Tim
@TimKong_
Followers
105
Following
464
Statuses
22
MD/PhD candidate @WUSTLmed | @mcgillu alum | MPN and AML cancer biology @ Oh Lab @mpndoc
Joined June 2021
3
0
2
RT @mpndoc: Thrilled to share our study now online @BloodJournal dissecting the role of NFκB signaling effectors in MPN disease biology! #m…
0
14
0
RT @WashURadOnc: The lab of @CarlDeSelm has been very busy! Two new publications-one reporting on use of low dose radiation to improve #leu…
0
5
0
RT @mpndoc: Deepest gratitude to @ale_baldu & @lizzyg100 for the opportunity to share our collaborative studies with @DipaolaJorge led by @…
0
4
0
RT @mpndoc: 🚨Just under the wire before the end of 2022, we are thrilled to announce our manuscript out today @NatureCancer “DUSP6 mediates…
0
25
0
RT @mpndoc: Fresh off Oh/Di Paola lab @WUSTLPostdoc Fan He's outstanding #ASH22 oral, we are thrilled to share our preprint on these exciti…
0
11
0
RT @Devin_Heroux: GOLD FOR CANADA 🇨🇦 THEY DID IT! Aaron Brown. Jerome Blake. Brendon Rodney. And Andre De Grasse. Loving Saturday nig…
0
1K
0
Congratulations to first-author @anthonyzwang and co-author @ClaraLiu97 for the first characterization of human dura and meningioma using scRNA-seq and IMC! Very impressed with my classmates publishing during GR1 phase of their MSTP training @WUSTLmstp @WUSTLImmuno @WashUGenetics
Fresh #SingleCell research! @GavinGpdunn @allegra_petti & Co @MassGenBrigham & @WUSTLmed use single-cell RNA seq to characterize non-tumor-associated human dura and primary meningioma for the 1st time, revealing immune and non-immune cellular landscapes.
1
0
4
RT @WUSTLdbbs: Congratulations to @WUSTLdbbs's own Dr. Stephen Oh (@mpndoc), who has received a 5-year $2.46M @nih_nhlbi grant for to estab…
0
3
0
RT @mpndoc: #WomenInScience day live look-in on Oh lab @WUSTLdbbs @WashUCancerBio student @MBrakhane putting in the work in her preferred h…
0
3
0
RT @CD_AACR: From the January issue: Characterization of the Genomic and Immunological Diversity of Malignant #BrainTumors Through Multi-Se…
0
7
0
Big congratulations to @mpndoc for this accomplishment! Fantastic clinician, scientist, and mentor indeed.
1
0
10
First co-first author paper in the Oh lab!! Here we utilize NFkB pathways inhibitors to target this hyperactive cascade in MPN/AML. Thanks to collaborators including @HmzaCelik @challenlab. #canigraduatenow
1/ Pleased to share our latest now online in Blood Advances demonstrating that the NEDD8 activating enzyme inhibitor pevonedistat targets the NFκB pathway to inhibit MPN cell growth and reduce disease burden in MPN mouse models.
0
0
16